251 related articles for article (PubMed ID: 15816636)
1. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
[TBL] [Abstract][Full Text] [Related]
2. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
Ayhan A; Baykal C; Al A; Ayhan A
Gynecol Oncol; 2001 Dec; 83(3):569-74. PubMed ID: 11733974
[TBL] [Abstract][Full Text] [Related]
3. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
6. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
10. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
11. Expression of thymidine phosphorylase in human cervical cancer.
Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
[TBL] [Abstract][Full Text] [Related]
12. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
15. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
Obermair A; Wanner C; Bilgi S; Speiser P; Reisenberger K; Kaider A; Kainz C; Leodolter S; Breitenecker G; Gitsch G
Cancer; 1998 Feb; 82(4):689-96. PubMed ID: 9477101
[TBL] [Abstract][Full Text] [Related]
16. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
17. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
18. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim H; Kim W; Lee M; Song E; Loh JJ
Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
20. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
